Afuco™ Anti-MS4A1 ADCC Therapeutic Antibody (Ublituximab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD20. Anti-Human CD20 Therapeutic Antibody is an immunomodulator. It binds to CD20.
Supplier Creative Biolabs
Product # AFC-TAB-207
Pricing Inquiry
Host Chimeric
Target MS4A1
Species Reactivity Human
Type ADCC enhanced antibody
Applications ELISA, IP, FC, FuncS, Neut, IF
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback